With CDC backing reinstated, AstraZeneca ships FluMist for the coming flu season

Having missed two flu seasons, AstraZeneca is looking to a comeback in the U.S. with its nasal-spray flu vaccine FluMist Quadrivalent on the back of CDC vaccine advisory group endorsement, but supply is limited.